At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 65 enrolled
Drug / intervention
CLiRpath Photoablation Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
CLiRpath® Excimer Laser System to Enlarge Lumen Openings
In Brief
A Phase 3 clinical trial evaluating CLiRpath Photoablation System for Peripheral Artery Disease. Completed, enrolled 65 participants.
Detailed Summary
The objective of this study is to evaluate the safety and efficacy of the CLiRpath® Photoablation Atherectomy System consisting of the Bias Sheath guiding catheter, in combination with the available CLiRpath® Excimer Laser Catheters ≤ 2.0 mm, to create larger lumens for treatment within the superficial femoral and popliteal arteries above the knee.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Artery Disease
Countries--
Collaborators--
Timeline
Phase 3CompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartNov 2006
Primary CompletionApr 2007
First PostedJan 2008
Study CompletionApr 2008
TodayJul 2026
First PostedJan 16, 2008
Enrollment StartNov 1, 2006
Primary CompletionApr 1, 2007
Study CompletionApr 1, 2008
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 18.5 years ago
Interventions
CLiRpath Photoablation Systemdevice
Use of CLiRpath Laser Catheter to improve vessel lumen diameter.